LVEF-based ICD Classifier
LVEF threshold assessment
Enter the measured left ventricular ejection fraction to view an educational decision-support summary.
CLINICAL
REFERENCE
REFERENCE
How to interpret this tool
This tool places LVEF into broad categories for educational decision support. LVEF is only one component of sudden cardiac death risk assessment and ICD decision-making.
Threshold summary
| LVEF | Output | Important limitation |
|---|---|---|
| ≤35% | Threshold met for further assessment | Does not establish eligibility by itself. |
| 36–40% | Individualized assessment | Selected etiologies may require additional risk stratification. |
| >40% | No routine primary-prevention indication based on LVEF alone | Other indications may apply regardless of LVEF. |
Before deciding on primary-prevention ICD
- Confirm diagnosis, etiology, and LVEF measurement.
- Consider NYHA class, optimized GDMT and appropriate reassessment interval.
- Account for time since MI, revascularization, and potentially reversible causes.
- Consider meaningful survival, competing risks, patient goals, and device-related harms.
- Apply disease-specific guidance for genetic or other cardiomyopathies and arrhythmic syndromes.
References
Heidenreich PA, et al.2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation. 2022;145:e895–e1032. DOI: 10.1161/CIR.0000000000001063.
Zeppenfeld K, et al.2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43:3997–4126. DOI: 10.1093/eurheartj/ehac262.
Al-Khatib SM, et al.2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Circulation. 2018;138:e272–e391. DOI: 10.1161/CIR.0000000000000549.
Clinical disclaimer: For professional education and decision support only. Do not use this LVEF-only classifier as a substitute for current guideline review, multidisciplinary assessment, or individualized clinical judgment. ICD indications differ by etiology, primary versus secondary prevention, symptoms, treatment status, timing, comorbidities, and disease-specific risk markers.
PERSONAL WORKSPACE
Clinical notes
Document key findings and keep a structured record for your own reference.
Private by design. Notes are stored in this browser on this device only. They are not uploaded to Appcardio.
Export or share this note
PERSONAL WORKSPACE
My notes
Review, edit, or remove notes saved in this browser.
Stored locally on this device
QUALITY & SAFETY
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.
Please describe the issue clearly. For calculation concerns, include the input values and expected result where possible.